Monday, february 28, 2022
Implementation of a liquidity contract
Ramsay Générale de Santé (Code ISIN: FR0000044471 / Stock symbol: GDS) has entrusted Crédit Industriel et Commercial SA (CIC), with the implementation of a liquidity contract concerning its ordinary shares listed on Euronext Paris as of March 1st 2022, for a period of one year renewable by tacit agreement.
The contract is in accordance with the provisions of the legal framework in force, in particular Regulation (EU) No. 596/2014 of the European Parliament and of the European Council of 16 April 2014 on market abuse (MAR), of the Delegated Regulation Commission (EU) No. 2017/567, Articles L. 22-10-62 et seq. of the French Commercial Code and Decision No. 2021-01 of the French Financial Markets Authority (Autorité des Marchés Financiers- AMF) of 22 June 2021 renewing the introduction of liquidity contracts on equity securities as an accepted market practice (the "AMF Decision") and any other provisions referred to therein.
The following means have been allocated to the liquidity account for the implementation of this contract:
• 200,000 euros
• 5,000 shares
The execution of the liquidity contract may be suspended according to conditions outlined in article 5 of AMF Decision No. 2021-01 of June 22 2021. It may also be suspended at the request of the Company for the period it specifies.
The contract may be terminated by Ramsay Générale de Santé at any time without notice, or by CIC with one month’s notice.
CIC may terminate the contract when the Liquidity Provider contract between it and Euronext Paris is terminated.
After the acquisition of the Capio Group in 2018, Ramsay Santé has become the leading European provider of comprehensive healthcare services. The group now has 36,000 employees and works with nearly 8,600 private practitioners.
Present in 5 countries, France, Sweden, Norway, Denmark and Italy, the group treats more than 7 million patients per year in its 350 facilities.
In hospitalization, Ramsay Santé offers almost all medical and surgical treatments in three business lines: Medicine-Surgery-Obstetrics (MCO), Follow-up and Rehabilitation Care (SSR) and Mental Health. Wherever it is present, the group participates in public health service missions and in the health network of the country, as in Sweden where the group has more than a hundred local health centres.
The quality and safety of care is the group's priority in all the countries where it operates. This is why the group is today one of the references in modern medicine, especially in ambulatory surgery and enhanced recovery after surgery (ARS).
The group also invests more than €200 million every year in its establishments, whether in new surgical and imaging technologies, or in the construction and modernisation of establishments. It also innovates at the service of patients with new digital tools and by developing its organisations to improve the efficiency of care.
Monday, february 28, 2022